Novo Nordisk | NVO - Actif À Court Terme





Actif À Court Terme Changement Date
ANI Pharmaceuticals USD 825.43M 78.35M 2026-06
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Bausch Health Companies USD 6.52B 544M 2026-06
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Canopy Growth CAD 529.47M 4.8M 2026-03
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Drreddys Laboratories INR 301.98B 298.66B 2026-03
Eli Lilly USD 65.26B 591M 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Merck USD 36.68B 1.66B 2026-06
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Novartis USD 27.35B 744M 2026-06
Novo Nordisk DKK 208.7B 31.38B 2026-06
Novo Nordisk DKK 31.89B 145.42B 2026-06
Pacira USD 615.21M 100.25M 2026-06
Perrigo USD 2.45B 260.7M 2026-06
Phibro Animal Health USD 935.51M 41.44M 2026-06
Prestige Brands USD 496.81M 65.33M 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Supernus Pharmaceuticals USD 711.21M 12.28M 2026-09
Zoetis USD 6.36B 118M 2026-06